Chinese guidelines on the management of renal cell carcinoma (2015 edition)
about
MicroRNA-142-5p promotes cell growth and migration in renal cell carcinoma by targeting BTG3In-vivo relation between plasma concentration of sorafenib and its safety in Chinese patients with metastatic renal cell carcinoma: a single-center clinical study.RECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis.The tumor suppressor role of microRNA-338-3p in renal cell carcinoma.Clival metastasis of renal clear cell carcinoma: Case report and literature review
P2860
Chinese guidelines on the management of renal cell carcinoma (2015 edition)
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Chinese guidelines on the management of renal cell carcinoma (2015 edition)
@ast
Chinese guidelines on the management of renal cell carcinoma (2015 edition)
@en
Chinese guidelines on the management of renal cell carcinoma (2015 edition)
@nl
type
label
Chinese guidelines on the management of renal cell carcinoma (2015 edition)
@ast
Chinese guidelines on the management of renal cell carcinoma (2015 edition)
@en
Chinese guidelines on the management of renal cell carcinoma (2015 edition)
@nl
prefLabel
Chinese guidelines on the management of renal cell carcinoma (2015 edition)
@ast
Chinese guidelines on the management of renal cell carcinoma (2015 edition)
@en
Chinese guidelines on the management of renal cell carcinoma (2015 edition)
@nl
P2093
P2860
P1476
Chinese guidelines on the management of renal cell carcinoma (2015 edition)
@en
P2093
Aiping Zhou
CSCO Renal Cell Carcinoma Committee
Dengfeng Cao
Dingwei Ye
Fangjian Zhou
Houjie Liang
Jianhui Ma
P2860
P356
10.3978/J.ISSN.2305-5839.2015.11.21
P407
P50
P577
2015-11-01T00:00:00Z